Acceleron Pharma Inc is categorized under Biotechnology Products and Services in Cambridge, MA .
Acceleron Pharma Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number 5417114 by the NAICS.
If you are seeking more information, feel free to contact John Knopf, Chief Executive Officer at the company’s single location by writing to 128 Sidney St, Cambridge, Massachusetts MA 02139 or by phoning (617) 649-9200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acceleron Pharma Inc |
| Contact Person: | John Knopf, Chief Executive Officer |
| Address: | 128 Sidney St, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 649-9200 |
| Website Address: | acceleronpharma.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| SIC Code: | 8731 |
| NAICS Code: | 5417114 |
| Share This Business: |
Acceleron Pharma Inc was started in 0 to provide professional Biotechnology Products and Services under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Knopf, Chief Executive Officer for inquiries that concern Acceleron Pharma Inc by calling the company number (617) 649-9200, as your correspondence is most welcome. Additionally, the physical location of the single location of Acceleron Pharma Inc can be found at the coordinates 42.35969,-71.10316 as well as the street address 128 Sidney St in Cambridge, Massachusetts 02139.
For its online presence, you may visit Acceleron Pharma Inc’s website at acceleronpharma.com and engage with its social media outlets through on Twitter and on Facebook.